Your browser doesn't support javascript.
loading
[Research progress of mesenchymal stem cells in female reproductive medicine].
Zhao, J; Wang, H B; Deng, Chengyan.
Afiliación
  • Zhao J; Department of Reproductive Medicine, Fuyang People's Hospital, Fuyang 236000, China.
  • Wang HB; Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, National Clinical Research Center for Gynecology and Obstetrics, State Key Laboratory of Difficult Severe and Rare Diseases, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
  • Deng C; Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, National Clinical Research Center for Gynecology and Obstetrics, State Key Laboratory of Difficult Severe and Rare Diseases, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
Zhonghua Yu Fang Yi Xue Za Zhi ; 56(12): 1709-1715, 2022 Dec 06.
Article en Zh | MEDLINE | ID: mdl-36536555
Stem cells have been a hot spot in medical research for a long time and have unique advantages in tissue repair, diagnosis and treatment of diseases. With the development of regenerative medicine, stem cells have been widely studied and applied in reproductive medicine, such as improving ovarian function and repairing endometrial damage. These efforts are achieved primarily through the use of mesenchymal stem cells(MSCs) from a variety of sources. However, the application of stem cells also faces problems such as low cell retention rate and medical ethics. This article focuses on the research progress and clinical application of MSCs (not involving embryonic stem cells) in the field of female reproductive medicine.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trasplante de Células Madre Mesenquimatosas / Células Madre Mesenquimatosas Límite: Female / Humans Idioma: Zh Revista: Zhonghua Yu Fang Yi Xue Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trasplante de Células Madre Mesenquimatosas / Células Madre Mesenquimatosas Límite: Female / Humans Idioma: Zh Revista: Zhonghua Yu Fang Yi Xue Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China